Advises private equity firms and their portfolio companies on Foreign Corrupt Practices Act and adjacent international risk issues in hundreds of cross-border transactions.
Leads international internal investigations into anti-corruption, kickbacks, violations of sanctions, money laundering, internal controls deficiencies, and other related misconduct for private equity firms and their portfolio companies.
Counsels fund sponsors on anti-money laundering matters, including program design and higher-risk investor onboarding.
Designs and implements compliance policies, procedures, and systems of internal controls related to a range of international risk matters.
Represented a hospital network in multi-jurisdictional shareholder litigation arising out of an equity restructuring.
Advised a private equity firm in connection with several ongoing actions and investigations arising out of the False Claims Act and state law analogs.
Represented a healthcare provider in a dispute over a multi-year sponsorship agreement.
Represented a private equity firm in post-closing litigation arising out of a price dispute in an infrastructure transaction.
Represented a major national healthcare provider in a qui tam action related to insurance reimbursements.
Represented global private equity firms in an SEC investigation into interactions with sovereign wealth funds.
Counseled a medical device manufacturer in connection with an FDA regulatory action.
Advised a major revenue cycle management company in connection with a federal regulatory action.
Represented a major retail company in connection with a false claims action.
Advised a private equity fund in connection with an SEC investigation into its valuation process.
Counseled a healthcare company vice president in an SEC insider trading investigation.
Represented fund trustees in an SEC investigation into a potential violation of the ‘40 Act.
Represented a Malian woman in a defensive asylum proceeding before the U.S. Immigration Court.
